By Date

Enhancing competition in on-patent markets

Health System Performance Assessment Framework for the Czech Republic

The health system performance assessment (HSPA) framework for the Czech Republic is an initiative designed to help the Czech health system improve policy planning, monitoring, and decision taking. This report describes the HSPA framework for the Czech Republic, its development process, governance structure and implementation roadmap. It also details the Czech HSPA framework domains, populated by indicators selected through a comprehensive review process. As such, the framework enables the assessment of strengths and weaknesses of the Czech health system. Its implementation will increase the accountability of national authorities and principal healthcare stakeholders, improve public involvement, smooth flow of information across the health sector, and allow reform planning and monitoring.

Reviews of National Healthcare Quality

OECD Healthcare Quality Reviews seek to examine what works and what does not work in different countries – both to benchmark the efforts of countries and to provide advice on reforms to improve their health system.

Integrating Care to Prevent and Manage Chronic Diseases - Best Practices in Public Health

Private Health Insurance

The OECD Study on Private Health Insurance was completed between 2001 and 2004, and assessed the role that private health insurance (PHI) plays in OECD member countries. This page lists all reports released as part of the study.

Public Health Reviews

This series of OECD Reviews of Public Health provide in-depth analysis and policy recommendations to strengthen priority areas of countries’ public health systems, highlighting best practice examples that allow learning from shared experiences, and the spreading of innovative approaches.

Pharmaceutical Pricing Policy project

The OECD Pharmaceutical Pricing Policy project had two main objectives: to add to the base of information about pharmaceutical pricing policy in OECD countries and develop a taxonomy and framework for making international comparisons of policies, and to analyse cross-national impacts and implications of policies, particularly with respect to the impacts on pharmaceutical prices paid in other countries and on pharmaceutical R&D.

Healthcare prices and Purchasing Power Parities

Variations in per capita health spending can be the result of differences in prices for healthcare goods and services, and in the quantity of care that individuals are using (“volume”). Eurostat and the OECD have calculated purchasing power parities and price level indexes for GDP and some 50 product groups, including health and hospitals, on a regular and timely basis.

International Trade in Health Services

Medical tourism is apparently growing rapidly and yet there is little data on the extent of the provision of health care services across borders. This OECD paper identifies the key emerging policy issues relating to the rise in this new market.